US Supreme Court rejects 'Pharma Bro' Martin Shkreli's appeal of penalties
The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug's price by more than 4,
Supreme Court Snubs Martin Shkreli’s Last-Ditch Bid to Avoid $64 Million Fine
There were no generic alternatives to a lifesaving drug when Shkreli jacked up its price by more than $700 per pill in 2015.
Supreme Court Denies Shkreli’s $64M Disgorgement Rehearing
The U.S. Supreme Court declined on Monday to review former pharmaceutical executive Martin Shkreli's challenge to a $64 million disgorgement order, which was imposed after his alleged scheme to raise the price of a life-saving drug by 4,
Supreme Court Rejects Appeals From R. Kelly and 'Pharma Bro' Martin Shkreli
The U.S. Supreme Court on Monday rejected appeals from two high-profile figures: R&B singer R. Kelly, and former pharmaceutical executive Martin Shkreli, known as "Pharma Bro." Kelly, who is serving a 20-year prison sentence, sought to challenge his conviction on child sex abuse charges.
Supreme Court Snubs Martin Shkreli's $64.6 Million Appeal
The U.S. Supreme Court refused to hear Martin Shkreli's appeal against a $64.6 million penalty imposed for steeply raising a drug's price. The penalty was equivalent to profits made from the price hike of Daraprim in 2015,
Opinion
Supreme Court declines appeals from R. Kelly, X, Martin Shkreli, Texas officer convicted in killing
The Supreme Court rejected appeals in high-profile cases regarding singer R. Kelly, Martin Shkreli and a former Texas police officer.
Supreme Court rejects appeal from ‘Pharma Bro’ Martin Shkreli
The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug.
Supreme Court rejects Martin Shkreli fine appeal
Martin Shkreli in 2022 was banned from the pharmaceutical industry and ordered to disgorge profits earned from raising the price of the drug Daraprim.
Supreme Court turns away Martin Shkreli fine appeal
Mr. Shkreli was convicted of defrauding investors and sentenced in 2018 to seven years in prison; he served about five years. A federal judge also banned Mr. Shkreli from the pharmaceutical industry and ordered him to pay $64.6 million.
Supreme Court Denies Shkreli's $64.6 Million Penalty Appeal
The Supreme Court declined to hear Martin Shkreli's appeal against a $64.6 million penalty for raising a drug's price by over 4,000%. The penalty corresponds to profits from raising Daraprim's price and includes a lifetime ban from the drug industry.
US Supreme Court rejects ex-pharma CEO Martin Shkreli's appeal
The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug's price by more than 4,
SCOTUS denial ends saga of Shkreli’s infamous 5,000% drug price scheme
The legal saga over Martin Shkreli's infamous 5,000 percent price hike of a life-saving anti-parasitic drug has ended with a ...
Dueling remembrances of Oct. 7
“On October 7th, Hamas displayed such viciousness to try to scare Israelis, Americans and the world into submission – but ...